Literature DB >> 21749500

Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy?

P Cabrera-Freitag1, M J Goikoetxea, C Beorlegui, P Gamboa, G Gastaminza, M Fernández-Benítez, M Ferrer, M Blanca, M L Sanz.   

Abstract

BACKGROUND: Few data on the diagnostic accuracy in pollinosis of the microarray ISAC of allergens are available.
OBJECTIVE: We aim to comparatively analyse ISAC CRD103 with the whole-extract ImmunoCAP in grass and cypress pollen allergy, evaluating the suitability of the manufacturer's recommended cut-off points for both techniques.
METHODS: We studied 120 atopic patients grouped into grass and cypress pollen-allergic patients and controls based on clinical history and skin prick tests. Specific IgE against Phleum pratense and Cupressus arizonica by ImmunoCAP and ISAC CRD103 were performed on all subjects.
RESULTS: In the grass pollen group (43 allergic/26 controls), both microarray and CAP showed high sensitivity (Se) and specificity (Sp) values (ISAC: Se 97.7, Sp 92.3; CAP: Se 95.3, Sp 96.1) for recommended cut-off points. Comparing the optimal (ISAC: 0.4 ISU; CAP: 0.33 kU/L) with the recommended cut-off points within the same technique, diagnostic agreement was observed in both techniques. Thus, CAP and ISAC showed similar diagnostic performance in grass pollen allergy when using recommended cut-off points. In cypress pollen group (12 allergic/92 controls), the microarray (Se: 91.7, Sp 91.3) showed similar Se but significantly higher Sp (P=0.034) than CAP (Se: 91.7, Sp: 80.4) using recommended cut-off points. However, although diagnostic performance of the microarray did not change when comparing the optimal (0.82 ISU) with the recommended cut-off point, CAP improved diagnosis of cypress pollen allergy, when applying the optimal (0.66 kU/L)(CAP Se: 91.7, Sp: 89.1) instead of the manufacturer's recommended cut-off point. Thus, when the most suitable cut-off point for both techniques (ISAC: 0.3 ISU; CAP: 0.66 kU/L) is selected, microarray and CAP provide equivalent diagnoses. CONCLUSIONS AND CLINICAL RELEVANCE: Component-based microarray ISAC CRD103 and whole-allergen CAP showed high Se and Sp diagnosing equally grass and cypress pollen allergy. The cut-off point for each allergen should be properly applied for both techniques.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749500     DOI: 10.1111/j.1365-2222.2011.03818.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

1.  Anaphylaxislike cholinergic urticaria.

Authors:  Darío Antolín-Amérigo; Petruta Cristina Vlaicu; Belén De La Hoz Caballer; Moisés Sánchez Cano
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

2.  Comparison of Component-Resolved Diagnosis by Using Allergen Microarray With the Conventional Tests in Allergic Rhinitis Patients: The First Using in Korea.

Authors:  Joo Hyun Jung; Il Gyu Kang; Seon Tae Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

Review 3.  Molecular approaches to allergen standardization.

Authors:  Martin D Chapman; Peter Briza
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 4.  Molecular approach to allergy diagnosis and therapy.

Authors:  Fatima Ferreira; Martin Wolf; Michael Wallner
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

5.  Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future.

Authors:  Désirée Larenas-Linnemann; Jorge A Luna-Pech; Ralph Mösges
Journal:  World Allergy Organ J       Date:  2017-09-19       Impact factor: 4.084

6.  Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

Authors:  Christian Lupinek; Eva Wollmann; Alexandra Baar; Srinita Banerjee; Heimo Breiteneder; Barbara M Broecker; Merima Bublin; Mirela Curin; Sabine Flicker; Tetiana Garmatiuk; Heidrun Hochwallner; Irene Mittermann; Sandra Pahr; Yvonne Resch; Kenneth H Roux; Bharani Srinivasan; Sebastian Stentzel; Susanne Vrtala; Leanna N Willison; Magnus Wickman; Karin C Lødrup-Carlsen; Josep Maria Antó; Jean Bousquet; Claus Bachert; Daniel Ebner; Thomas Schlederer; Christian Harwanegg; Rudolf Valenta
Journal:  Methods       Date:  2013-10-22       Impact factor: 3.608

7.  Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children.

Authors:  Yvonne Resch; Sven Michel; Michael Kabesch; Christian Lupinek; Rudolf Valenta; Susanne Vrtala
Journal:  J Allergy Clin Immunol       Date:  2015-05-05       Impact factor: 10.793

8.  Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis.

Authors:  Johannes Huss-Marp; Jan Gutermuth; Ina Schäffner; Ulf Darsow; Florian Pfab; Knut Brockow; Johannes Ring; Heidrun Behrendt; Thilo Jakob; Christoph Ahlgrim
Journal:  Allergo J Int       Date:  2015-03-14

9.  A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics.

Authors:  Giorgio Walter Canonica; Ignacio J Ansotegui; Ruby Pawankar; Peter Schmid-Grendelmeier; Marianne van Hage; Carlos E Baena-Cagnani; Giovanni Melioli; Carlos Nunes; Giovanni Passalacqua; Lanny Rosenwasser; Hugh Sampson; Joaquin Sastre; Jean Bousquet; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2013-10-03       Impact factor: 4.084

10.  Is the determination of specific IgE against components using ISAC 112 a reproducible technique?

Authors:  Rubén Martínez-Aranguren; María T Lizaso; María J Goikoetxea; Blanca E García; Paula Cabrera-Freitag; Oswaldo Trellez; María L Sanz
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.